We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IDTI
101
DELISTED
Integrated Device Technology I
IDTI
| $2.84M | 0.27% |
144,886
-6,342
| -4% | -$109K |
|
102
MacroGenics
MGNX
$235M
| $2.82M | 0.27% |
80,456
-18,530
| -19% | -$462K |
|
|
UCTT
103
Ultra Clean Holdings
UCTT
$4.16B
| $2.79M | 0.27% |
300,530
+229,502
| +323% | +$1.94M |
|
|
FDML
104
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $2.77M | 0.26% |
172,397
+83,991
| +95% | +$1.29M |
|
105
Tidewater
TDW
$3.91B
| $2.77M | 0.26% |
+2,646
| New | +$3M |
|
106
CACI
CACI
$10.8B
| $2.76M | 0.26% |
+32,057
| New | +$2.61M |
|
107
Hanover Insurance
THG
$7.63B
| $2.73M | 0.26% |
38,227
-151
| -0.4% | -$10.2K |
|
|
ATSG
108
DELISTED
Air Transport Services Group
ATSG
| $2.72M | 0.26% |
317,240
+207,944
| +190% | +$1.66M |
|
|
109
Omnicell
OMCL
$1.86B
| $2.71M | 0.26% |
81,742
-166,703
| -67% | -$5.15M |
|
|
CORE
110
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.68M | 0.26% |
86,440
-21,706
| -20% | -$630K |
|
111
TechTarget
TTGT
$246M
| $2.67M | 0.25% |
234,711
+104,480
| +80% | +$1.05M |
|
|
AMSG
112
DELISTED
Amsurg Corp
AMSG
| $2.63M | 0.25% |
48,089
-42,825
| -47% | -$2.18M |
|
|
UNT
113
DELISTED
UNIT Corporation
UNT
| $2.62M | 0.25% |
76,778
+62,348
| +432% | +$2.7M |
|
|
QLGC
114
DELISTED
QLOGIC CORP
QLGC
| $2.62M | 0.25% |
196,526
+149,712
| +320% | +$1.7M |
|
115
Leidos
LDOS
$14.1B
| $2.6M | 0.25% |
59,855
+25,942
| +76% | +$1.02M |
|
116
AMN Healthcare
AMN
$1.28B
| $2.58M | 0.25% |
131,407
-52,569
| -29% | -$903K |
|
117
Comtech Telecommunications
CMTL
$51.8M
| $2.57M | 0.25% |
81,469
+39,062
| +92% | +$1.42M |
|
|
GTS
118
DELISTED
Triple-S Management Corporation
GTS
| $2.56M | 0.24% |
112,423
+78,157
| +228% | +$1.67M |
|
|
BBG
119
DELISTED
Bill Barrett Corp
BBG
| $2.45M | 0.23% |
+215,265
| New | +$2.84M |
|
|
MN
120
DELISTED
MANNING & NAPIER, INC.
MN
| $2.41M | 0.23% |
174,578
+101,023
| +137% | +$1.53M |
|
121
ICU Medical
ICUI
$3.93B
| $2.39M | 0.23% |
+29,216
| New | +$2.24M |
|
|
BIG
122
DELISTED
Big Lots, Inc.
BIG
| $2.39M | 0.23% |
59,623
+41,913
| +237% | +$1.86M |
|
123
NeoGenomics
NEO
$1.81B
| $2.26M | 0.22% |
542,231
-322,861
| -37% | -$1.48M |
|
|
EXAC
124
DELISTED
Exactech Inc
EXAC
| $2.25M | 0.21% |
95,334
+36,325
| +62% | +$803K |
|
|
TRK
125
DELISTED
Speedway Motorsports, Inc.
TRK
| $2.23M | 0.21% |
+102,138
| New | +$2M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.